NASDAQ:KMDA
Kamada Ltd.
- Stock
industry
Drug Manufacturers / Specialty & Genericexchange
NASDAQ Global Selectwebsite
www.kamada.comipo date
Aug 01, 2005full time employees
380currency
USD
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus